Brian Carr has extensive experience in drug metabolism and pharmacokinetics (DMPK), currently serving as Executive Director of Biologics DMPK at Gilead Sciences since December 2013, with previous roles including Senior Director and Senior Research Scientist II in the same field. Prior to joining Gilead Sciences, Brian Carr held various positions at Merck from 2003 to 2013, culminating in the role of Director of Preclinical DMPK. Brian Carr obtained a degree from the University of Utah between 1996 and 2002.
This person is not in the org chart
This person is not in any teams
This person is not in any offices